ALBAWABA - Hims & Hers Health, a direct-to-consumer pharmaceutical firm, announced that injectable GLP-1 weight reduction medications are available for just a small portion of the price of name-brand rivals like Wegovy and Ozempic, causing the startup’s stock to shoot up 30 percent after the news. The company plans to provide the compounded GLP-1 medication for a starting price point of $199, 85 percent less than competitions like Wegovy and ...